Facet Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Facet Wealth's VRTX Position: Q3 2026 in Review
Facet Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 62% in Q3 2026, buying an estimated $152K and bringing the position to 772 shares worth $404K. The position accounts for 0.01% of the portfolio, ranked #287.
Facet Wealth first reported a position in VRTX in Q2 2025 and has held it in 5 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Facet Wealth held 772 shares of Vertex Pharmaceuticals worth $404K as of Q3 2026.
- Facet Wealth bought 296 Vertex Pharmaceuticals shares in Q3 2026, an estimated $152K.
- Vertex Pharmaceuticals made up 0.01% of Facet Wealth's portfolio in Q3 2026, its #287 holding.
- Facet Wealth first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Facet Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.